These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. High complete remission rate and promising outcome by combination of imatinib and chemotherapy for newly diagnosed BCR-ABL-positive acute lymphoblastic leukemia: a phase II study by the Japan Adult Leukemia Study Group. Yanada M, Takeuchi J, Sugiura I, Akiyama H, Usui N, Yagasaki F, Kobayashi T, Ueda Y, Takeuchi M, Miyawaki S, Maruta A, Emi N, Miyazaki Y, Ohtake S, Jinnai I, Matsuo K, Naoe T, Ohno R, Japan Adult Leukemia Study Group. J Clin Oncol; 2006 Jan 20; 24(3):460-6. PubMed ID: 16344315 [Abstract] [Full Text] [Related]
3. Additional chromosomal abnormalities and variability of BCR breakpoints in Philadelphia chromosome/BCR-ABL-positive acute lymphoblastic leukemia in Taiwan. Ko BS, Tang JL, Lee FY, Liu MC, Tsai W, Chen YC, Wang CH, Sheng MC, Lin DT, Lin KH, Tien HF. Am J Hematol; 2002 Dec 20; 71(4):291-9. PubMed ID: 12447959 [Abstract] [Full Text] [Related]
12. Clinical significance of dual color-dual fusion translocation fluorescence in situ hybridization in the detection of bcr/abl fusion gene. Wu B, Zhou S, Song L, Liu X. Zhonghua Zhong Liu Za Zhi; 2002 Jul 20; 24(4):364-6. PubMed ID: 12408765 [Abstract] [Full Text] [Related]
13. [Clinical characteristics and outcomes of 59 patients with acute lymphoblastic leukemia positive for BCR/ABL]. Liu Z, Liu XL, Du QF, Xu N, Zhong M, Song LL, Yi ZS, Liu QF, Meng FY, Zhou SY. Nan Fang Yi Ke Da Xue Xue Bao; 2009 Mar 20; 29(3):512-5. PubMed ID: 19304540 [Abstract] [Full Text] [Related]
14. Achieving a major molecular response at the time of a complete cytogenetic response (CCgR) predicts a better duration of CCgR in imatinib-treated chronic myeloid leukemia patients. Iacobucci I, Saglio G, Rosti G, Testoni N, Pane F, Amabile M, Poerio A, Soverini S, Bassi S, Cilloni D, Bassan R, Breccia M, Lauria F, Izzo B, Merante S, Frassoni F, Paolini S, Montefusco E, Baccarani M, Martinelli G, GIMEMA Working Party on Chronic Myeloid Leukemia. Clin Cancer Res; 2006 May 15; 12(10):3037-42. PubMed ID: 16707599 [Abstract] [Full Text] [Related]
17. Favorable outcome with STI571 (imatinib mesylate) and allogeneic stem cell transplantation in a case of Ph+ chemorefractory acute lymphocytic leukaemia. Wernstedt P, Brune M, Andersson PO, Gustavsson B, Stockelberg D, Wadenvik H. Bone Marrow Transplant; 2002 Dec 15; 30(12):971-3. PubMed ID: 12476293 [Abstract] [Full Text] [Related]
18. [Monitoring of minimal residual disease in patients with chronic myeloleukemia: clinical value of real-time polymerase chain reaction]. Chelysheva EIu, Turkina AG, Misiurin AV, Aksenova EV, Domracheva EV, Zakharova AV, Khoroshko ND. Ter Arkh; 2007 Dec 15; 79(4):49-53. PubMed ID: 17564019 [Abstract] [Full Text] [Related]